Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cedric J Carter

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Postgraduate Medicine|December 6, 2017
New developments in acute anticoagulation therapyCedric J Carter
Pharmacotherapy|June 25, 2003
Frequency of heparin-induced thrombocytopenia in critical care patientsArun K Verma, Marc Levine, Stephen J Shalansky, et al.
Platelets|August 29, 2003
Comparison of thrombopoiesis during ITP and HIV-ITP and response to intravenous gammaglobulin treatmentMaria I C Gyongyossy-Issa, James B Bussel, Cedric J Carter, et al.
Transfusion|February 26, 2017
Pathogen inactivation treatment of plasma and platelet concentrates and their predicted functionality in massive transfusion protocolsAhmad F Arbaeen, Peter Schubert, Katherine Serrano, et al.
British Journal of Haematology|August 26, 2010
A novel compensating mechanism for homozygous coagulation factor V deficiency suggested by enhanced activated partial thromboplastin time after reconstitution with normal factor VKimberley Talbot, Jina Song, Jeff Hewitt, et al.
Transfusion|February 27, 2008
Buffy-coat platelet variables and metabolism during storage in additive solutions or plasmaJerry G Zhang, Cedric J Carter, Brankica Culibrk, et al.
Science Translational Medicine|October 31, 2014
Affinity-based design of a synthetic universal reversal agent for heparin anticoagulantsRajesh A Shenoi, Manu Thomas Kalathottukaren, Richard J Travers, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Postgraduate Medicine|December 6, 2017
New developments in acute anticoagulation therapyCedric J Carter
Pharmacotherapy|June 25, 2003
Frequency of heparin-induced thrombocytopenia in critical care patientsArun K Verma, Marc Levine, Stephen J Shalansky, et al.
Platelets|August 29, 2003
Comparison of thrombopoiesis during ITP and HIV-ITP and response to intravenous gammaglobulin treatmentMaria I C Gyongyossy-Issa, James B Bussel, Cedric J Carter, et al.
Transfusion|February 26, 2017
Pathogen inactivation treatment of plasma and platelet concentrates and their predicted functionality in massive transfusion protocolsAhmad F Arbaeen, Peter Schubert, Katherine Serrano, et al.
British Journal of Haematology|August 26, 2010
A novel compensating mechanism for homozygous coagulation factor V deficiency suggested by enhanced activated partial thromboplastin time after reconstitution with normal factor VKimberley Talbot, Jina Song, Jeff Hewitt, et al.
Transfusion|February 27, 2008
Buffy-coat platelet variables and metabolism during storage in additive solutions or plasmaJerry G Zhang, Cedric J Carter, Brankica Culibrk, et al.
Science Translational Medicine|October 31, 2014
Affinity-based design of a synthetic universal reversal agent for heparin anticoagulantsRajesh A Shenoi, Manu Thomas Kalathottukaren, Richard J Travers, et al.
Pageof 1